200 related articles for article (PubMed ID: 21091040)
1. The safety of clopidogrel.
Mangalpally KK; Kleiman NS
Expert Opin Drug Saf; 2011 Jan; 10(1):85-95. PubMed ID: 21091040
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.
Collet JP; Montalescot G; Steg PG; Steinhubl SR; Fox KA; Hu TF; Johnston SC; Hamm CW; Bhatt DL; Topol EJ
Arch Cardiovasc Dis; 2009; 102(6-7):485-96. PubMed ID: 19664568
[TBL] [Abstract][Full Text] [Related]
3. Prasugrel: Clinical development and therapeutic application.
Guerra DR; Tcheng JE
Adv Ther; 2009 Nov; 26(11):999-1011. PubMed ID: 20020231
[TBL] [Abstract][Full Text] [Related]
4. Controversy of proton pump inhibitor and clopidogrel interaction: a review.
Tan HJ
J Dig Dis; 2010 Dec; 11(6):334-42. PubMed ID: 21091895
[TBL] [Abstract][Full Text] [Related]
5. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
; Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Eikelboom JW; Fox KA; Granger CB; Jolly S; Joyner CD; Rupprecht HJ; Widimsky P; Afzal R; Pogue J; Yusuf S
N Engl J Med; 2010 Sep; 363(10):930-42. PubMed ID: 20818903
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel in acute coronary syndrome: implications of recent study findings.
Duerschmied D; Bode C; Moser M
Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1215-29. PubMed ID: 20828343
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic thrombocytopenic purpura associated with clopidogrel.
Bennett CL; Connors JM; Carwile JM; Moake JL; Bell WR; Tarantolo SR; McCarthy LJ; Sarode R; Hatfield AJ; Feldman MD; Davidson CJ; Tsai HM
N Engl J Med; 2000 Jun; 342(24):1773-7. PubMed ID: 10852999
[TBL] [Abstract][Full Text] [Related]
8. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
Walker CW; Dawley CA; Fletcher SF
Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
[No Abstract] [Full Text] [Related]
9. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
Cannon CP; Husted S; Harrington RA; Scirica BM; Emanuelsson H; Peters G; Storey RF;
J Am Coll Cardiol; 2007 Nov; 50(19):1844-51. PubMed ID: 17980250
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel. Bleeding and resistance.
Ball J
BMJ; 2009 May; 338():b1927. PubMed ID: 19457954
[No Abstract] [Full Text] [Related]
11. Potential Interaction between clopidogrel and proton pump inhibitors.
Howard PA; Vacek JL
Am J Cardiovasc Drugs; 2009; 9(6):353-9. PubMed ID: 19929033
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel in acute coronary syndromes.
Chua D; Ignaszewski A
BMJ; 2009 Apr; 338():b1180. PubMed ID: 19366756
[No Abstract] [Full Text] [Related]
13. Thrombotic thrombocytopenic purpura associated with clopidogrel administration: case report and brief review.
Nara W; Ashley I; Rosner F
Am J Med Sci; 2001 Sep; 322(3):170-2. PubMed ID: 11570785
[TBL] [Abstract][Full Text] [Related]
14. Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk.
Lazar LD; Lincoff AM
Cleve Clin J Med; 2009 Dec; 76(12):707-14. PubMed ID: 19952295
[TBL] [Abstract][Full Text] [Related]
15. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
16. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
17. Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?
Cuisset T; Frere C; Quilici J; Uhry S; Alessi MC; Bonnet JL
Int J Cardiol; 2010 Jan; 138(2):212-3. PubMed ID: 18707772
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.
Steg PG; James S; Harrington RA; Ardissino D; Becker RC; Cannon CP; Emanuelsson H; Finkelstein A; Husted S; Katus H; Kilhamn J; Olofsson S; Storey RF; Weaver WD; Wallentin L;
Circulation; 2010 Nov; 122(21):2131-41. PubMed ID: 21060072
[TBL] [Abstract][Full Text] [Related]
19. Is clopidogrel adequate in 2013?
Wheatcroft S
Cardiovasc J Afr; 2013 Mar; 24(2):45. PubMed ID: 23750347
[No Abstract] [Full Text] [Related]
20. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
